Laurisa of INJXU on Regenerative Aesthetics, Restraint, and Why the Industry Needs to Slow Down
After my first visit to INJXU — where dermal therapist Elle redirected me from the treatment I’d booked and toward something my skin actually needed — I found myself wanting to understand more. Not just about what happened in that room, but about the philosophy behind it. So I sat down with Laurisa, INJXU’s founder and registered nurse, to talk about where aesthetics is heading, and why she believes the most important shift in the industry isn’t a new device or injectable. It’s a different way of thinking about skin altogether.
FROM VOLUME TO REGENERATION
The conversation about injectables has changed. If you’ve been in the aesthetics space for a few years, you’ll have noticed it — a quieter, more considered energy replacing the race for immediate results. Laurisa has been watching this shift closely, and she has a clear view of what’s driving it.
“It’s a three-way conversation between patients, practitioners, and the science catching up with what we see clinically,” she tells me. “Patients are asking for subtle, long-term results instead of quick fixes, and as practitioners, we’re far more focused on preserving structure, function, and collagen rather than chasing volume.”
The science, she says, has finally confirmed what good clinicians have long suspected: that chronic inflammation, collagen loss, and barrier dysfunction drive visible ageing. Filling over unhealthy tissue without addressing the underlying biology, in her view, is simply incomplete medicine.
This is what she means by the word “regenerative” — a term now appearing across the industry, though not always with the same intent. For Laurisa, it has a precise meaning. “Regenerative aesthetics leans into collagen stimulation, improved extracellular matrix quality, and better barrier health, so the skin actually functions more like a younger, healthier organ over time.” Not softening lines at the surface. Not adding volume. Improving how the tissue behaves.
THE SKIN AS AN ORGAN
“Skin-first in clinical practice means we treat the skin as an organ before we treat it as a canvas.”
The phrase “skin-first” is gaining currency in aesthetic medicine, though like many terms that cross from clinical practice into marketing, it risks being hollowed out. I ask Laurisa what it actually means when you’re standing in a consultation room.
“In real terms, it looks like correcting barrier dysfunction, chronic inflammation, and texture or pigment issues before we start adding volume or chasing individual lines,” she says. It shifts the question from ‘What can I inject today?’ to ‘What does your skin actually need to function well over the next five to ten years?’
The patients coming through her door now are, she says, more educated than ever — arriving with questions about collagen pathways, inflammatory load, and skin longevity. Her role has evolved accordingly. “My role has become less about providing a treatment and more about educating, interpreting the science, and building a phased plan that respects their biology, lifestyle, and tolerance for downtime.”
And when injectables are used in isolation — without this foundation — the results often betray themselves. “You can end up with over-filled faces where the texture, tone, and elasticity don’t match the volume,” she explains, “which actually draws more attention to the work that’s been done.”
THE ART OF RESTRAINT
If skin-first is the philosophy, restraint is the practice. And it is, Laurisa argues, one of the most underrated clinical skills in aesthetics.
“Knowing when not to inject is just as critical as knowing how,” she says. “Long-term success depends on protecting facial identity, respecting anatomical limits, and considering how today’s decisions will look in five or ten years — not just in a selfie next week.”
That kind of thinking — protecting the face’s future as much as its present — is what I experienced in my own visit. Being redirected from the treatment I’d planned wasn’t a disappointment. In hindsight, it was exactly the kind of considered clinical decision that Laurisa is describing.
She is equally clear about where the industry has fallen short. “We’ve had a long phase of over-treating and over-correcting, often with very little consideration for what the skin and underlying structures can tolerate over decades, not just months.”
TREATMENT STACKING: THINKING IN LAYERS
One of the most compelling ideas Laurisa articulates is the concept of treatment stacking — combining injectables with energy-based therapies like RF microneedling, laser, ultrasound, and LED. Not as a menu of add-ons, but as a genuinely integrated approach.
“Ageing doesn’t happen at a single layer,” she says simply. “Treating only with injectables gives a partial, often short-lived result.” When therapies are combined thoughtfully — addressing structure, collagen, texture, pigment, and inflammation together — the outcomes are more natural and tend to last longer.
There is, she emphasises, a correct order. “In most cases, we prioritise skin integrity and collagen work first, allow time for healing and remodelling, and then layer injectables once the tissue is calmer and more robust.” The skin needs space to respond. Overwhelm it, and nothing performs at its best.
For a patient committed to both visible results and long-term skin health, she describes an ideal 6–12 month journey that is phased, not rushed: corrective skincare and energy-based treatments first, then strategic injectables once the foundation is solid, then ongoing collagen-building work in the months that follow. Fewer, more considered appointments. Treatments spaced further apart.
WHAT THE NEXT FIVE YEARS LOOK LIKE
“The most beautiful, lasting results happen when we honour the skin as an intelligent organ — not something to fix or chase trends with.”
I ask Laurisa where she sees regenerative aesthetics heading, and her answer is characteristically considered. She sees the industry moving from correction toward optimisation — away from filling and freezing, toward supporting how skin and underlying tissues actually function.
“The clinics that lead will be the ones that can translate this science into clear, structured programs for patients — combining injectables, skin health, and wellness in a way that feels personalised, subtle, and sustainable,” she says.
And the message she most wants patients to leave with? That the most lasting results come from honouring the skin as an intelligent organ. “For me, injectables are one considered tool within a much larger framework that includes collagen support, inflammation control, barrier repair, and the way you live day to day.”
The empowering part, she adds, is that patients are not passive recipients in that process. Sleep, stress, sun, skincare, consistency — the choices made outside the clinic shape the results inside it.
I think about my own experience at INJXU: walking in with a plan, leaving with a better one. A thorough conversation before a single product was applied. A space that felt warm and considered rather than cold and transactional.
That, it turns out, is not just good customer experience. It is the philosophy, expressed in practice.
Visit Injxu Face + Skin to learn more
Words by Kris Abbey
